Boston Scientific Corp. stock outperforms competitors
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors
Boston Scientific Corp. closed $1.60 below its 52-week high ($84.12), which the company achieved on September 13th.
Boston Scientific Corporation (BSX) Stock: Beyond the Surface of Its Performance?
Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $82.52 which represents a decrease of $-0.99 or -1.19% from the prior close of $83.51. The stock opened at $83.33 and touched a low of $81.
Boston Scientific Corporation (BSX): Among Morgan Stanley’s Best Stock Picks for 2025
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against Morgan Stanley’s other stock picks.
Boston Scientific Corp. stock underperforms Monday when compared to competitors despite daily gains
Boston Scientific Corp. closed $0.61 short of its 52-week high ($84.12), which the company reached on September 13th.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank,
Pick Boston Scientific Stock After 130% Gains?
Investors have rewarded BSX stock thanks to the uptick in its sales for its new products and the Watchman line.
Boston Scientific Corp. stock outperforms competitors despite losses on the day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top
What's Behind The 2x Rise In Boston Scientific Stock?
We estimate Boston Scientific’s Valuation to be $83 per share, aligning with its current levels of $82. At its current levels, BSX stock is trading at 8.2x revenues. The 8.2x figure is higher than the stock’s average P/S ratio of 5.
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: ...
WBJournal1d
Boston Scientific closes $1.2B acquisition of California stroke prevention device maker
Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical ...
Boston Scientific’s Buy Rating: TAVR Developments Signal Market Growth and Revenue Potential
Bank of America Securities analyst Travis Steed has maintained their bullish stance on BSX stock, giving a Buy rating on September 5. Travis ...
Is there really such a thing as "pregnancy brain"?
BOSTON - There's more scientific proof that there is such a thing as "pregnancy brain." Every year, millions of pregnant women experience profound physical and hormonal changes, but what specifically ...
MassDevice1d
FDA approves expanded label for Boston Scientific Ingevity+ pacing leads
Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...
Boston Scientific (BSX) Gets a Buy from Wells Fargo
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), ...